Skip to main content
logo
Nexien BioPharma, Inc. (NXEN)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 6, 2026

Nexien BioPharma Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Net Income
-0.19-0.24-0.36-0.63-1.86-2.67
Other Amortization
0.050.050.050.040.01-
Stock-Based Compensation
0.050.080.20.160.660.09
Other Operating Activities
-0.0100.020.341.092.39
Change in Accounts Payable
0.040.0300.010-0.03
Change in Other Net Operating Assets
00.01-0-000.06
Operating Cash Flow
-0.06-0.06-0.08-0.08-0.09-0.15
Operating Cash Flow Growth
------

Financing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Short-Term Debt Issued
-0.03-0.170.10.01
Total Debt Issued
0.060.03-0.170.10.01
Net Debt Issued (Repaid)
0.060.03-0.170.10.01
Issuance of Common Stock
---0--
Financing Cash Flow
0.060.03-0.170.10.01

Net Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Net Cash Flow
-0-0.03-0.080.10.01-0.14

Free Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Levered Free Cash Flow
0.020.020.030.05-0.5-1.43
Unlevered Free Cash Flow
0.020.020.030.04-0.5-1.43

Additional Metrics

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Change in Working Capital
0.040.0400.010.010.04